CLINICAL_TRIALS
trial_result
· 2012-04-09
Clinical Trial Update: Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis [Phase 2]
Summary
Phase 2 clinical trial evaluating adalimumab (Humira) for refractory non-infectious uveitis has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oregon Health and Science University | Conditions: Uveitis | Phase 2 | Status: COMPLETED | Results posted: 2012-04-09